Homology Medicines SG&A Expense (TTM) Analysis

Homology Medicines Inc (DELISTED) (FIXX:DL)

0.9347 -15.76 (-94.40%) USD | NASDAQ | Mar 25, 16:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	31.26M
September 30, 2023	31.50M
June 30, 2023	32.47M
March 31, 2023	32.32M
December 31, 2022	38.14M
September 30, 2022	40.77M
June 30, 2022	41.31M
March 31, 2022	42.32M
December 31, 2021	36.84M
September 30, 2021	33.64M
June 30, 2021	33.71M
March 31, 2021	33.46M
December 31, 2020	32.57M

Date	Value
September 30, 2020	30.77M
June 30, 2020	28.38M
March 31, 2020	25.13M
December 31, 2019	22.21M
September 30, 2019	21.52M
June 30, 2019	19.32M
March 31, 2019	18.31M
December 31, 2018	17.28M
September 30, 2018	14.88M
June 30, 2018	12.76M
March 31, 2018	10.21M
December 31, 2017	8.279M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

19.32M

Minimum

Jun 2019

42.32M

Maximum

Mar 2022

31.98M

Average

32.47M

Median

Jun 2023

SG&A Expense (TTM) Benchmarks